BPA’s role as an endocrine disrupter is not in dispute. As vom Saal states, “Low doses of endocrine disrupters act in ways that are totally unpredicted by the traditional approaches of toxicology.” That is to say, per vom Saal’s studies, very low doses of compounds such as BPA have been shown to give rise to the array of health issues previously listed. In toxicological jargon, this behavior manifests as “non-monotonic dose-response curves.”

Read more